1.
Paller AS, Silverberg JI, Hong C- ho, Cork M, Puig L, Arlert P, Kurbasic A, Soldbro L, Simpson EL. The impact of tralokinumab on quality of life and school in patients aged 12–17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2022Nov.16 [cited 2023Dec.8];6(6):s77. Available from: https://jofskin.org/index.php/skin/article/view/1835